Invivyd, Inc. (NASDAQ:IVVD) Financings

Invivyd, Inc.

Financings

RaiseDate
Public offering of common stock and pre-funded warrants
Announced: about US$125M · US$2.5 a share · Cantor +1
Dealers: Cantor (lead), H.C. Wainwright & Co.
Use of proceeds: Commercial preparedness for potential VYD2311 launch, R&D on RSV and measles programs, SPEAR Study Group efforts, working capital and general corporate purposes
Nov 18, 2025
At-the-market programme of at-the-market (ATM) offering facility
Closed: US$29.8M raised
Nov 6, 2025
Public offering of common stock and pre-funded warrants
Closed: US$57.5M raised · US$0.52 a share · Cantor
Dealers: Cantor (lead)
Buyers: RA Capital Management; Janus Henderson Investors
Use of proceeds: VYD2311 clinical program, RSV and measles pipeline R&D, SPEAR Study Group efforts, working capital and general corporate purposes
Aug 22, 2025

Read by 6ix AI from the company's releases